Literature DB >> 32521002

Antibody Profiles in Mild and Severe Cases of COVID-19.

Zhi-Li Liu1, Yang Liu2, La-Gen Wan2, Tian-Xin Xiang3, Ai-Ping Le4, Peng Liu2, Malik Peiris5, Leo L M Poon5, Wei Zhang6.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32521002      PMCID： PMC7314168          DOI： 10.1093/clinchem/hvaa137

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  22 in total

Review 1. 

Authors:  Paul Van Caeseele; Dana Bailey; Sarah E Forgie; Tanis C Dingle; Mel Krajden
Journal:  CMAJ       Date:  2020-12-07       Impact factor: 8.262

2.  SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS.

Authors:  Marie-Luise Buchholtz; Florian M Arend; Peter Eichhorn; Michael Weigand; Alisa Kleinhempel; Kurt Häusler; Mathias Bruegel; Lesca M Holdt; Daniel Teupser
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

3.  Interim analysis of the clinical performance of five SARS-Cov-2 serology assays.

Authors:  Michael J Knauer; Benjamin D Hedley; Vipin Bhayana; Michael Payne; Ian Chin-Yee; Johan Delport
Journal:  Clin Biochem       Date:  2020-09-06       Impact factor: 3.281

4.  SARS-CoV-2 antibodies titration: a reappraisal.

Authors:  Giuseppe Lippi; Mario Plebani
Journal:  Ann Transl Med       Date:  2020-08

5.  Antibody response to SARS-CoV-2 in people living with HIV.

Authors:  Shinya Yamamoto; Makoto Saito; Etsuko Nagai; Keiko Toriuchi; Hiroyuki Nagai; Hiroshi Yotsuyanagi; Yu Nakagama; Yasutoshi Kido; Eisuke Adachi
Journal:  J Microbiol Immunol Infect       Date:  2020-10-02       Impact factor: 4.399

6.  Landscape of epitopes targeted by T cells in 852 individuals recovered from COVID-19: Meta-analysis, immunoprevalence, and web platform.

Authors:  Ahmed Abdul Quadeer; Syed Faraz Ahmed; Matthew R McKay
Journal:  Cell Rep Med       Date:  2021-05-21

7.  SARS-CoV-2 infection: diagnostic testing results occasionally require special attention.

Authors:  Elisabetta Riva; Pier Paolo Sainaghi; Ombretta Turriziani; Guido Antonelli; Giuseppe Patti
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

Review 8.  Updates on laboratory investigations in coronavirus disease 2019 (COVID-19).

Authors:  Giuseppe Lippi; Brandon M Henry; Fabian Sanchis-Gomar; Camilla Mattiuzzi
Journal:  Acta Biomed       Date:  2020-09-07

9.  Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease.

Authors:  Timothy Cardozo; Ronald Veazey
Journal:  Int J Clin Pract       Date:  2020-12-04       Impact factor: 2.503

10.  Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France.

Authors:  S Edouard; P Colson; C Melenotte; F Di Pinto; L Thomas; B La Scola; M Million; H Tissot-Dupont; P Gautret; A Stein; P Brouqui; P Parola; J-C Lagier; D Raoult; Michel Drancourt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-11-11       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.